Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
Инструмент Всемирной Организации Здравоохранения для Оценки Систем Психического Здоровья
(ИОСПЗ-ВОЗ) представляет собой новый инструмент, предназначенный для с...ора основной
информации о системе психического здоровья в стране или регионе. Целью сбора такой
информации является улучшение систем охраны психического здоровья и оказания
психиатрической помощи. В ИОСПЗ-ВОЗ система психического здоровья определяется как
совокупность всех видов деятельности, основной целью которой является пропаганда,
восстановление или поддержание психического здоровья. Система психического здоровья
включает все организации и ресурсы, нацеленные на улучшение психического здоровья.
more
Health Information Translations provides education resources in multiple languages for health care professionals and others to use in their communities. Resources are easy to read and culturally appropriate.
The use of the World Health Organization Health System Performance Assessment Framework
PURPOSE: To assess the appropriateness of computerizing a health facility warehouse. If users are interested in receiving technical assistance to improve and/or computerize the logistics information system, Management Sciences for Health (MSH) will analyze the responses to determine the initial step...s in this process.
DESCRIPTION: A multiple-choice, self-evaluation questionnaire that covers basic information about the type and quantity of products managed in the warehouse; the procurement, distribution, and inventory management processes; and information technology. Analysis guidelines help users assess the usefulness and feasibility of computerization and determine their management system's readiness for computerizing the logistics management information system.
more
Accessed 18 June 2018 | Last updated 1-Jun.-2018 (data as of 25-May-2018) | Next overall update Mid-July 2018
Manual for Early Implementation
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...ion of pharmaceutical products.
more
The Global Antimicrobial Resistance Surveillance System (GLASS) is a platform for global data sharing on antimicrobial resistance worldwide. It has been launched by WHO as part of the implementation of the Global Action Plan on Antimicrobial Resistance (AMR). The data generated will help to inform n...ational, regional and global decision-making, strategies and advocacy.
more
Guide to enrolment for antimicrobial resistance national focal points
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
10 Janaury 2022 The following catalogue lists all the medical devices including personal protective equipment, medical equipment, medical consumables, single use devices and laboratory and test related devices.
Os itens neste catálogo representam uma seleção prioritária inicial e estão sujeitos a revisões constantes. Nada neste catálogo deve ser interpretado como oferta ou garantia de alocação de suprimentos. Os custos dos itens são apenas estimativas.
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...LASS report.
The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017.
The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy.
more
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance... of antimicrobial consumption (AMC), invasive fungal infections, and a One Health surveillance model relevant to human health. To meet future challenges, it is in continuous evolution to enhance the quality and representativeness of data to inform the AMR burden accurately. As of the end of 2022, 127 countries, territories and areas participate in GLASS.
The fifth GLASS report, produced in collaboration with Member States, summarizes 2020 data on AMR rates in common bacteria from countries, territories, and areas. The report brings new features, including analyses of population testing coverage or AMR trends. For the first time, the report presents 2020 data on AMC at the national level. A new interactive dashboard allow users to explore AMR and AMC global data, country profiles and download the data.
This report marks the end of the early implementation phase of GLASS. In addition to presenting data collected through the latest data call, this report provides a summary of five years of national AMR surveillance data contributed to GLASS from its initiation, presents AMR findings in the context of progress of country participation in GLASS and in global AMR surveillance coverage and laboratory quality assurance systems at (sub)national level.
Patterns of antimicrobial consumption are presented by country with a particular focus on antibacterials. The report also presents the antimicrobial consumption according to the WHO AWaRe antibiotic classification, for penicillins and cephalosporines. From a One Health perspective, the report presents antimicrobial consumption data in the human sector expressed in tons to allow a comparison with antimicrobial consumption from other sectors (not included in this report).
more